It’s the latest step from pharmacy benefit managers to respond to relentless criticism from politicians and regulators over ...

Reports Q4 revenue $65.65B, consensus $63.18B. “While higher medical costs in our stop loss product impacted fourth quarter earnings, we are ...

Sees FY25 adjusted revenue at least $252,000. Sees FY25 capital expenditures $1.4B. Sees FY25 effective tax rate 19%. The company said, “The ...

Last year, it was clear that evolving cybersecurity trends and challenges had far-reaching impacts across all industries.